Applied Genetic Technologies (AGTC) Secures $10M Milestone Payment Following Treatment of First Patient of Second Cohort in Phase 1/2 Clinical XLRP Study
Tweet Send to a Friend
Applied Genetic Technologies Corporation (NASDAQ: AGTC) today announced that it has enrolled the first patient of the second cohort in ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
